| 中文名 | N-Boc-4-(4-甲苯磺酰氧基甲基)哌啶 |
|---|---|
| 英文名 | N-Tert-Butoxycarbonyl-4-(4-Toluenesulfonyloxymethyl)Piperidine |
| 中文别名 |
1-叔丁氧羰基-4-(对二甲苯磺酸基)哌啶
N-Boc-4-(4-甲基苯磺酰氧甲基)哌啶 N-BOC-4-(4-甲基苯磺酸甲基)哌啶 1-N-BOC-4-(4-甲基苯磺酰氧甲基)哌啶(凡德他尼中间体) 1-BOC-4-对甲苯磺酰氧基哌啶 N-BOC-4-(4-甲基苯磺酰氧甲基)哌啶 4-[(4-甲基苯基)磺酰氧基甲基]哌啶-1-羧酸叔丁酯 4-[(4-甲基苯基)磺酰氧基甲基]-1-哌啶-1-羧酸叔丁酯 4-[[(4-甲苯基磺酰基)氧基]甲基]哌啶-1-羧酸叔丁酯 1-BOC-4-[(对甲苯磺酰基氧基)甲基]哌啶 凡德他尼侧链 1-BOC-4-(P-甲苯磺酰氧甲基)哌啶 1-BOC-4-(对二甲苯磺酸基)哌啶 N-BOC-4-(4-甲苯磺酰氧基甲基)哌啶 1-Boc-4-(对二甲苯磺酸基)哌啶 4-({[(4-甲基苯基)磺酰基]氧基}甲基)哌啶-1-甲酸叔丁酯 1-BOC-4-(O-对甲苯磺酰基-羟甲基)哌啶 4-[(4-甲基苯基)磺酰氧基甲基]哌啶-1-甲酸叔丁酯 1-叔丁氧羰基-4-[(对二甲苯磺酸基)甲基]哌啶 |
| 英文别名 |
1-(tert-Butoxycarbonyl)-4-(tosyloxymethyl)piperidine
1-Boc-4-(tosyloxyMethyl)piperidine tert-butyl 4-{[(4-methylbenzenesulfonyl)oxy]methyl}piperidine-1-cboxylate N-tert-Butoxycbonyl-4-(4-toluenesulfonyloxymethyl)piperidi 2-Methyl-2-propanyl 4-({[(4-methylphenyl)sulfonyl]oxy}methyl)-1-piperidinecarboxylate tert-butyl 4-({[(4-methylphenyl)sulfonyl]oxy}methyl)piperidine-1-carboxylate 1-(tert-Butoxycarbonyl)-4-[(p-toluenesulfonyloxy)methyl]piperidine 1-N-BOC-4-(4-Methylbenzenesulfonyloxymethyl)piperidine 4-[[(4-Tolylsulfonyl)oxy]methyl]piperidine-1-cboxylic acid tert-butyl ester 1-Boc-4-(p-toluenesulfonyloxyMethyl)piperidine 1-Boc-4-(tosyloxymethyl)piperidine 166-9 tert-Butyl 4-((tosyloxy)Methyl)piperidine-1-cboxylate 1-(tert-Butoxycbonyl)-4-[(p-toluenesulfonyloxy)methyl]piperidine> 4-[(4-methylphenyl)sulfonyloxymethyl]piperidine-1-cboxylic acid tert-butyl ester 1-piperidinecboxylic acid, 4-[[[(4-methylphenyl)sulfonyl 1-(tert-Butoxycbonyl)-4-(tosyloxymethyl)piperidine N-tert-Butoxycbonyl-4-(4-toluenesulphonyloxymethyl)piperidine N-Boc-4-(4-toluenesulfonyloxymethyl)piperidine 1-N-bOC-4-(4-TOLUENESULFONYLOXYMETHYL)PIPERIDINE 1-(tert-Butoxycbonyl)-4-[(p-toluenesulfonyloxy)methyl]piperidine tert-Butyl 4-((tosyloxy) N-TERT-BUTOXYCBONYL-4-(4-TOLUENESULFONYLOXYMETHYL)PIPERIDINE 4-[(4-methylphenyl)sulfonyloxymethyl]-1-piperidinecboxylic acid tert-butyl ester tert-Butyl 4-({[(4-methylphenyl)sulfonyl]-oxy}methyl)piperidine-1-carboxylate N-(tert-Butoxycbonyl)-4-(tosyloxymethyl)piperidine 1-Boc-4-(p-toluenesulfonyloxymethyl)piperidine tert-butyl 4-({[(4-methylphenyl)sulfonyl]oxy}methyl)piperidine-1-cboxylate 1-Piperidinecarboxylic acid, 4-[[[(4-methylphenyl)sulfonyl]oxy]methyl]-, 1,1-dimethylethyl ester N-Boc-4-(4-Toluenesulfonyloxymethyl)piperidine 1-PIPERIDINECBOXYLIC ACID, 4-[[[(4-METHYLPHENYL)SULFONYL]OXY]METHYL]-, 1,1-DIMETHYLETHYL ESTER N-tert-Butoxycbonyl-4-(4-toluenesulfonyloxymethyl) |
| 密度 | 1.2±0.1 g/cm3 |
|---|---|
| 沸点 | 487.8±18.0 °C at 760 mmHg |
| 熔点 | 74 °C |
| 分子式 | C18H27NO5S |
| 分子量 | 369.476 |
| 闪点 | 248.8±21.2 °C |
| 精确质量 | 369.160980 |
| PSA | 81.29000 |
| LogP | 2.90 |
| 外观性状 | 固体;White to Orange to Green powder to crystal |
| 蒸汽压 | 0.0±1.2 mmHg at 25°C |
| 折射率 | 1.526 |
| 储存条件 | 室温 |
| 水溶解性 | 可溶于:甲醇 |
| 危害码 (欧洲) | Xi |
|---|---|
| 海关编码 | 2933399090 |
|
~88%
166815-96-9 |
| 文献:Chiesi Farmaceutici S.p.A.; RANCATI, Fabio; Rizzi, Andrea; Linney, Ian; Blackaby, Wesley; Knight, Chris Patent: US2013/34504 A1, 2013 ; Location in patent: Paragraph 0147; 0148; 0149 ; |
|
~85%
详细
|
| 文献:AstraZeneca AB Patent: US7235559 B1, 2007 ; US 7235559 B1 |
|
~%
166815-96-9 |
| 文献:US5763458 A1, ; US 5763458 A |
|
~%
166815-96-9 |
| 文献:US2004/48881 A1, ; US 20040048881 A1 |
|
~%
166815-96-9 |
| 文献:Journal of Labelled Compounds and Radiopharmaceuticals, , vol. 42, # 13 p. 1289 - 1300 |
| 上游产品 6 | |
|---|---|
| 下游产品 6 | |
| 海关编码 | 2933399090 |
|---|---|
| 中文概述 | 2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |